USANA HEALTH SCIENCES INC's ticker is USNA and the CUSIP is 90328M107. A total of 144 filers reported holding USANA HEALTH SCIENCES INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,650,605 | -0.1% | 36,486 | +7.1% | 0.00% | 0.0% |
Q1 2024 | $1,651,951 | -10.7% | 34,061 | -1.3% | 0.00% | 0.0% |
Q4 2023 | $1,849,453 | -9.7% | 34,505 | -1.3% | 0.00% | 0.0% |
Q3 2023 | $2,047,928 | -5.7% | 34,942 | +1.4% | 0.00% | 0.0% |
Q2 2023 | $2,171,475 | +98783.2% | 34,446 | -1.4% | 0.00% | -33.3% |
Q1 2023 | $2,196 | +24.8% | 34,919 | +5.6% | 0.00% | +50.0% |
Q4 2022 | $1,760 | -99.9% | 33,082 | +5.3% | 0.00% | -33.3% |
Q3 2022 | $1,760,000 | -22.9% | 31,402 | -0.5% | 0.00% | 0.0% |
Q2 2022 | $2,283,000 | -7.8% | 31,544 | +1.2% | 0.00% | 0.0% |
Q1 2022 | $2,477,000 | -15.3% | 31,182 | +8.0% | 0.00% | -25.0% |
Q4 2021 | $2,923,000 | +6.6% | 28,885 | -2.9% | 0.00% | 0.0% |
Q3 2021 | $2,742,000 | -20.8% | 29,735 | -12.1% | 0.00% | -20.0% |
Q2 2021 | $3,464,000 | +2.8% | 33,816 | -2.1% | 0.01% | 0.0% |
Q1 2021 | $3,370,000 | +29.0% | 34,532 | +1.9% | 0.01% | +25.0% |
Q4 2020 | $2,612,000 | +4.1% | 33,882 | -0.6% | 0.00% | 0.0% |
Q3 2020 | $2,510,000 | -9.4% | 34,081 | -9.7% | 0.00% | -20.0% |
Q2 2020 | $2,770,000 | +14.4% | 37,723 | -10.0% | 0.01% | 0.0% |
Q1 2020 | $2,421,000 | -24.4% | 41,923 | +2.8% | 0.01% | 0.0% |
Q4 2019 | $3,203,000 | +18.5% | 40,780 | +3.2% | 0.01% | 0.0% |
Q3 2019 | $2,702,000 | +10.4% | 39,516 | +28.3% | 0.01% | 0.0% |
Q2 2019 | $2,447,000 | +71.1% | 30,806 | +80.6% | 0.01% | +66.7% |
Q1 2019 | $1,430,000 | -29.0% | 17,056 | -0.4% | 0.00% | -25.0% |
Q4 2018 | $2,015,000 | +44.3% | 17,116 | +47.8% | 0.00% | +33.3% |
Q3 2018 | $1,396,000 | -1.9% | 11,584 | -6.1% | 0.00% | 0.0% |
Q2 2018 | $1,423,000 | +55.5% | 12,340 | +15.8% | 0.00% | +50.0% |
Q1 2018 | $915,000 | +11.4% | 10,655 | -3.9% | 0.00% | 0.0% |
Q4 2017 | $821,000 | +9.0% | 11,082 | -15.1% | 0.00% | 0.0% |
Q3 2017 | $753,000 | -9.1% | 13,055 | +1.1% | 0.00% | 0.0% |
Q2 2017 | $828,000 | +17.4% | 12,910 | +5.4% | 0.00% | 0.0% |
Q1 2017 | $705,000 | -3.2% | 12,246 | +2.9% | 0.00% | 0.0% |
Q4 2016 | $728,000 | -8.0% | 11,897 | +108.1% | 0.00% | 0.0% |
Q3 2016 | $791,000 | +27.6% | 5,718 | +2.7% | 0.00% | 0.0% |
Q2 2016 | $620,000 | -9.2% | 5,566 | -1.1% | 0.00% | 0.0% |
Q1 2016 | $683,000 | -4.6% | 5,627 | +0.3% | 0.00% | 0.0% |
Q4 2015 | $716,000 | -9.6% | 5,608 | -5.0% | 0.00% | -33.3% |
Q3 2015 | $792,000 | +1.3% | 5,906 | +3.2% | 0.00% | +50.0% |
Q2 2015 | $782,000 | +13.8% | 5,722 | -7.4% | 0.00% | 0.0% |
Q1 2015 | $687,000 | +22.0% | 6,181 | +12.7% | 0.00% | 0.0% |
Q4 2014 | $563,000 | +24.6% | 5,485 | -10.7% | 0.00% | +100.0% |
Q3 2014 | $452,000 | -3.0% | 6,139 | +3.0% | 0.00% | 0.0% |
Q2 2014 | $466,000 | -6.0% | 5,959 | -9.4% | 0.00% | 0.0% |
Q1 2014 | $496,000 | -4.4% | 6,579 | -4.2% | 0.00% | -50.0% |
Q4 2013 | $519,000 | -13.5% | 6,869 | -0.6% | 0.00% | 0.0% |
Q3 2013 | $600,000 | +18.6% | 6,909 | -1.3% | 0.00% | 0.0% |
Q2 2013 | $506,000 | – | 6,997 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Euclidean Technologies Management, LLC | 42,276 | $3,195,000 | 2.92% |
Capital Impact Advisors, LLC | 21,373 | $1,615,000 | 1.30% |
Matarin Capital Management, LLC | 18,266 | $1,381,000 | 0.85% |
ALGERT GLOBAL LLC | 25,440 | $1,923,000 | 0.51% |
Phocas Financial Corp. | 125,970 | $10,231,000 | 0.48% |
Camarda Financial Advisors, LLC | 6,918 | $523,000 | 0.43% |
Wolf Group Capital Advisors | 6,645 | $502,000 | 0.40% |
Spark Investment Management LLC | 27,100 | $2,048,000 | 0.36% |
CLARK ESTATES INC/NY | 32,059 | $2,423,000 | 0.34% |
JAMES INVESTMENT RESEARCH, INC. | 118,515 | $8,957,000 | 0.28% |